Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.68% |
| 2 | Technology | 12.88% |
| 3 | Consumer Staples | 9.84% |
| 4 | Communication Services | 9.02% |
| 5 | Financials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
SI-BONE Inc
SIBN
$848M
| $2.68M | ﹤0.01% |
224,500
+159,200
| +244% | +$2.92M |
|
|
BCLI
1902
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $2.68M | ﹤0.01% |
38,443
+16,181
| +73% | +$1.26M |
|
1903
DXP Enterprises
DXPE
$3.12B
| $2.67M | ﹤0.01% |
218,064
+61,664
| +39% | +$1.78M |
|
|
LUMO
1904
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $2.66M | ﹤0.01% |
313,091
-13,358
| -4% | -$187K |
|
1905
Avient
AVNT
$4.25B
| $2.65M | ﹤0.01% |
139,858
-695,400
| -83% | -$19.5M |
|
1906
Allstate
ALL
$66.1B
| $2.64M | ﹤0.01% |
28,800
-116,500
| -80% | -$12.7M |
|
1907
Kodiak Sciences
KOD
$2.59B
| $2.64M | ﹤0.01% |
55,359
-244,000
| -82% | -$14.6M |
|
|
ARC
1908
DELISTED
ARC Document Solutions, Inc.
ARC
| $2.63M | ﹤0.01% |
3,249,338
-302,300
| -9% | -$349K |
|
1909
Belden
BDC
$5.31B
| $2.63M | ﹤0.01% |
72,893
-220,300
| -75% | -$10.1M |
|
1910
Chemung Financial Corp
CHMG
$405M
| $2.63M | ﹤0.01% |
79,688
-5,700
| -7% | -$207K |
|
|
MSGN
1911
DELISTED
MSG Networks Inc.
MSGN
| $2.63M | ﹤0.01% |
257,600
-706,600
| -73% | -$10.1M |
|
1912
Nicolet Bankshares
NIC
$3.75B
| $2.62M | ﹤0.01% |
47,995
-12,400
| -21% | -$834K |
|
1913
Spero Therapeutics
SPRO
$71.2M
| $2.62M | ﹤0.01% |
324,303
-13,900
| -4% | -$123K |
|
1914
Acadia Realty Trust
AKR
$2.86B
| $2.61M | ﹤0.01% |
210,417
+63,016
| +43% | +$1.42M |
|
|
EMKR
1915
DELISTED
Emcore Corp
EMKR
| $2.6M | ﹤0.01% |
116,227
-6,230
| -5% | -$184K |
|
1916
Customers Bancorp
CUBI
$2.82B
| $2.6M | ﹤0.01% |
237,466
-48,943
| -17% | -$948K |
|
1917
Ferrari
RACE
$72.9B
| $2.59M | ﹤0.01% |
17,000
-261,568
| -94% | -$42.2M |
|
|
TCDA
1918
DELISTED
Tricida, Inc. Common Stock
TCDA
| $2.59M | ﹤0.01% |
117,800
+87,600
| +290% | +$2.81M |
|
1919
Standard Motor Products
SMP
$870M
| $2.59M | ﹤0.01% |
62,300
+22,100
| +55% | +$1.04M |
|
|
OIIM
1920
DELISTED
02Micro International
OIIM
| $2.59M | ﹤0.01% |
2,012,174
-74,486
| -4% | -$108K |
|
1921
Westamerica Bancorp
WABC
$1.38B
| $2.58M | ﹤0.01% |
43,900
+1,269
| +3% | +$78.9K |
|
1922
Option Care Health
OPCH
$3.59B
| $2.57M | ﹤0.01% |
271,756
-137,583
| -34% | -$2.02M |
|
1923
Townsquare Media
TSQ
$104M
| $2.57M | ﹤0.01% |
558,437
+82,000
| +17% | +$679K |
|
|
BDSI
1924
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.57M | ﹤0.01% |
678,400
-432,951
| -39% | -$2.13M |
|
1925
Acadia Pharmaceuticals
ACAD
$4.87B
| $2.57M | ﹤0.01% |
60,800
-670,200
| -92% | -$27.6M |
|
Similar funds
Jim Simons's Q1 2020 Portfolio in Review
As of Q1 2020, Jim Simons held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jim Simons's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Jim Simons added most to Baidu in Q1 2020, an estimated $462M increase.
- Jim Simons's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Jim Simons fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Jim Simons's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Jim Simons opened 573 new positions and closed 645 in Q1 2020.
- Jim Simons's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.